![3-[(2-乙酰氧基)乙基氨基羰基]吡啶结构式](https://www.chemsrc.com/caspic/189/83440-03-3.png)
3-[(2-乙酰氧基)乙基氨基羰基]吡啶结构式
|
常用名 | 3-[(2-乙酰氧基)乙基氨基羰基]吡啶 | 英文名 | SG 209 |
|---|---|---|---|---|
| CAS号 | 83440-03-3 | 分子量 | 208.21400 | |
| 密度 | 1.182g/cm3 | 沸点 | 430.7ºC at 760 mmHg | |
| 分子式 | C10H12N2O3 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 214.3ºC |
3-[(2-乙酰氧基)乙基氨基羰基]吡啶用途SG-209 is a potassium channel opener. |
| 中文名 | 3-[(2-乙酰氧基)乙基氨基羰基]吡啶 |
|---|---|
| 英文名 | SG 209,N-[2-(Acetoxy)ethyl]-3-pyridinecarboxamide |
| 英文别名 | 更多 |
| 密度 | 1.182g/cm3 |
|---|---|
| 沸点 | 430.7ºC at 760 mmHg |
| 分子式 | C10H12N2O3 |
| 分子量 | 208.21400 |
| 闪点 | 214.3ºC |
| 精确质量 | 208.08500 |
| PSA | 68.29000 |
| LogP | 0.76540 |
| 外观性状 | 固体 |
| 折射率 | 1.521 |
| 储存条件 | -20°C， 密封， 干燥 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 安全声明 (欧洲) | 22-24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| 海关编码 | 2933399090 |
|
~%
3-[(2-乙酰氧基)乙基氨基羰基]吡啶 83440-03-3 |
| 文献：TERNANSKY, Robert Patent: WO2007/38772 A1, 2007 ; Location in patent: Example 2 ; WO 2007/038772 A1 |
| 3-[(2-乙酰氧基)乙基氨基羰基]吡啶上游产品 2 | |
|---|---|
| 3-[(2-乙酰氧基)乙基氨基羰基]吡啶下游产品 0 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.
J. Pharmacol. Exp. Ther. 354 , 79-87, (2015) Intense research is conducted to identify new molecular mechanisms of angiogenesis. Previous studies have shown that the angiogenic effects of hydrogen sulfide (H2S) depend on the activation of ATP-se... |
|
|
Nicorandil inhibits degranulation and TNF-alpha release from RBL-2H3 cells.
Inflamm. Res. 51 , 176-181, (2002) Nicorandil is a potassium channel opener and nitric oxide (NO) donor, and the hypothesis was tested that these modes of action may inhibit cellular degranulation and release of tumour necrosis factor-... |
|
|
A further study of the vasodilator and negative inotropic mechanisms of action of nicorandil and its congeners in the canine heart.
Cardiovasc. Drugs Ther. 8 , 227-234, (1994) The vasodilator and negative inotropic mechanisms of action of nicorandil and its congeners (SG-209, SG-103, and SG-86) were investigated in isolated canine papillary muscle preparations cross-circula... |
| sg 209 |
查看所有供应商和价格请点击：
